The placebo and the Declaration of Pachuca: dead letters?

Abstract

The Latin American and Caribbean Medical Confederation (CONFEMEL), an organization that brings together related organizations from countries of the region, works on behalf of the medical profession and the population’s health guided by international documents. During its General Assembly (Pachuca, Mexico; 2013) the Declaration of Pachuca was approved with strong critics regarding the review of the Declaration of Helsinki that occurred in Brazil and the issue of clinical trials that use placebo in diseases with known treatment. The strong and energetic tone of this Declaration proposes that member entities condemn ethical abuses in all forums and also to administrations so that they engage against the use of placebo in these conditions. These recommendations are supported in the global movement on Integrity and Ethics in Research. The conclusion addresses the importance of the educative role of ethical supervision of Medicine warning physicians who violate these guidelines, which are also incorporated in the Code of Medical Ethics, that they will be subjected to ethical-professional process.

Keywords:

Placebo, Declaration of Helsinki, Medicine, Biomedical research, Medical legislation, Integrity in research

How to Cite

1.
The placebo and the Declaration of Pachuca: dead letters?. Rev. bioét.(Impr.). [Internet]. 2014 Dec. 1 [cited 2024 Jul. 3];22(3). Available from: https://revistabioetica.cfm.org.br/revista_bioetica/article/view/953